https://orcid.org/0000-0002-6464-5604
Abstract
Background
Autoimmune diseases affect 5–10% of the global population and cause chronic pain and impaired functionality. Chronic pain management involves pharmacological and non-pharmacological interventions, with non-pharmacological options gaining attention as safe, effective, and cost-effective alternatives. However, further research is needed to determine the effectiveness of these therapies in African patients with autoimmune diseases, as existing evidence varies.
Methods
This review protocol has been registered in the International Prospective Register of Systematic Reviews (PROSPERO, CRD42023449896). Electronic databases (PubMed, Africa Index Medicus, Cochrane Library, CINAHL, PsycINFO, and Web of Science) will be used for searching published articles. The study will use R for data synthesis, employing a random-effects meta-analysis approach to calculate pooled effect sizes, assess heterogeneity using the I2 statistic, and evaluate publication bias. In conclusion, this protocol aims to fill the knowledge gap on non-pharmacological therapies for chronic pain in patients with autoimmune diseases in Africa. It will potentially enhance evidence-based decision-making to improve pain management and, hence, the quality of life of people with autoimmune diseases in Africa.
Citation: Gebremeskel GG, Haile TG, Gebrewahd GT, Hailay A, Aberhe W, Mebrahtom G, et al. (2024) Effectiveness of non-pharmacological therapies for chronic pain in people with autoimmune diseases in Africa: A protocol for a systematic review and meta-analysis. PLoS ONE 19(7): e0306564. https://doi.org/10.1371/journal.pone.0306564
Editor: Mickael Essouma, Universal Scientific Education and Research Network, UNITED KINGDOM
Received: July 25, 2023; Accepted: June 18, 2024; Published: July 2, 2024
Copyright: © 2024 Gebremeskel et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: We intend to make the deidentified research data will be made publicly available once the study is completed and published. As this is a protocol submission, we do not currently have any dataset.
Funding: The authors received no specific funding for this work.
Competing interests: The authors have declared that no competing interests exist.
Introduction
The availability of population-based data on autoimmune diseases (ADs) in Africa is limited. However, ADs affect approximately 5–10% of the global population [1, 2], and their prevalence is on the rise, leading to significant health and economic challenges for individuals and society [3]. ADs are chronic conditions characterized by inflammation, tissue damage, and a wide range of symptoms. This inflammation results from a breakdown of immune tolerance, leading the immune system to attack healthy tissues [4]. Among individuals with established ADs such as rheumatoid arthritis and lupus, chronic pain significantly affects most patients, potentially leading to impaired functionality, physical well-being, and reduced quality of life. Accordingly, the management of chronic pain is of paramount importance for people with ADs [5–7].
Both pharmacological and non-pharmacological interventions are used to manage chronic pain in ADs, and pharmacological treatments typically have a wide range of adverse effects because they are nondisease-specific and have broad action [8]. Non-pharmacological interventions include physical activity, lifestyle interventions, mindfulness-based interventions, and potentially complementary and alternative medicines. Complementary and alternative medicines could be important in the treatment of chronic pain in people with ADs in Africa because, according to a systematic review, 58.2% of people in sub-Saharan Africa use traditional and complementary alternative medicine for their health problems [9].
While the majority of research on non-pharmacological pain management in ADs has been conducted outside Africa, there is a need for further investigation into its effectiveness among patients with ADs in Africa, as existing evidence varies. Therefore, conducting a systematic review and meta-analysis can help address these discrepancies by pooling data and providing more reliable and comprehensive results on the effectiveness of non-pharmacological therapies for managing chronic pain in people with ADs in Africa. Additionally, this review will inform clinical practice, policymaking, and future research endeavors and ultimately improve the quality of life and health outcomes of patients with ADs in Africa.
Methods
Design
This protocol was reported according to the Preferred Reporting Items for Systematic Review and Meta-analysis Protocols (PRISMA-P) and registered in PROSPERO (CRD42023449896).
Search strategies
To identify relevant studies assessing the effectiveness of non-pharmacological therapies for chronic pain in people with ADs, a comprehensive search will be conducted across various important electronic databases. These electronic databases will be PubMed, Africa Index Medicus, the Cochrane Library, CINAHL, PsycINFO, and the Web of Science [10]. The search strategy will employ a combination of Medical Subject Headings (MeSH) terms for PubMed and appropriate indexing terms and keywords for other databases, utilizing appropriate Boolean operators (AND, OR). The search strategy will encompass all available literatures published from 2020 until the most up-to-date evidence at the time of manuscript submission. The search strategy will include relevant terms pertaining to four categories: 1) "ADs," 2) "chronic pain," 3) "non-pharmacological therapies," and 4) "Africa." The search terms are explained in S1 Table.
Eligibility criteria
Inclusion criteria.
- ➢ Population: All patients diagnosed with an ADs
- ➢ Intervention: Studies with non-pharmacological therapies
- ➢ Comparator: People with ADs without chronic pain in Africa
- ➢ Outcome: Studies that reported the effectiveness of non-pharmacological therapies for chronic pain
- ➢ Study designs: Randomized controlled trials, cohort studies, and qualitative studies
- ➢ Study setting: Studies conducted in Africa
- ➢ Language: Studies published in English
Data management and extraction
Two independent reviewers will extract data from the included studies using a standardized data extraction form. The extracted data will include study characteristics (e.g, author, year, country, sample size), participant characteristics (e.g., age, gender, AD type), intervention details (e.g., type, frequency, duration), outcomes, and adverse events.
More specifically, we will extract the following information: publication, authors, month, country, and type of publication. Additionally, study characteristics such as the design, setting, sample size, response rate, mean or median age, or age range of participants will be recorded. Outcomes of interest, including pain intensity, pain-related disability, quality of life, and adverse events, will also be extracted, along with information on the burden of chronic pain and its impact on patients’ lives. Outcome measures of interest will be pain intensity and pain interference. The secondary outcomes will be quality of life and adverse events.
Assessment of quality of evidence and risk of bias
The Newcastle-Ottawa quality assessment tool will be used to assess the methodological quality of cohort studies in this review [11]. In addition, we will utilize the Cochrane risk-of-bias tool and Critical Appraisal Skills Program (CASP) to assess the methodological quality of RCTs and qualitative studies respectively [12, 13].
Two independent reviewers will assess the risk of bias in the included studies using the Cochrane risk of bias tool. The tool assesses the risk of bias in the following domains: random sequence generation, allocation concealment, blinding of participants and personnel, blinding of outcome assessment, incomplete outcome data, selective reporting, and other sources of bias. Any disagreements will be resolved through discussion or consultation with a third reviewer.
Data synthesis and analysis
The data will be synthesized using a random-effects model meta-analysis. Heterogeneity will be assessed using the I2 statistic and the chi-squared test. Subgroup, sensitivity, and influence analysis (exploring possible effects of outliers) will be conducted to explore the potential sources of heterogeneity and to assess the robustness of the findings whenever necessary.
The data analysis will be conducted using R software, with the Metafor package utilized for calculating the standardized mean difference (SMD) with 95% confidence intervals (CIs) for continuous outcomes and the risk ratio (RR) with 95% CI for dichotomous outcomes. The resulting data will be presented through graphical and tabular summaries, such as forest plots and summary tables.
We will conduct subgroup analysis based on the type of non-pharmacological therapy, the type of AD, the duration of therapy, and the quality of the included studies. We will conduct a sensitivity analysis to assess the impact of removing studies with a high risk of bias or studies with a small sample size on the overall effect size. Publication bias will be assessed using Egger’s test and visual inspection of the funnel plots whenever possible.
Discussion
The aim of this systematic review and meta-analysis will be to assess the effectiveness of non-pharmacological therapies for managing chronic pain in patients with ADs in Africa. The overarching goal is to fill this knowledge gap and provide evidence-based insights in a context where research on this topic is limited. This review will analyze the available literature, including studies on interventions such as exercise, physical therapy, cognitive-behavioral therapy, mindfulness, meditation, mind-body therapies, traditional African herbal remedies, and self-management strategies. The systematic review will be published in accordance with the PRISMA guidelines [14].
Non-pharmacological therapies are essential for pain management in Africa due to their cost-effectiveness, cultural relevance, and minimal adverse effects. Exploring the effectiveness of traditional African medicines in managing chronic pain associated with ADs holds promise for a more inclusive and culturally sensitive healthcare approach in Africa. Patient perspectives on traditional remedies are increasingly important, and some plants, as evidenced by Khumalo GP et. al. (2022), have already shown promise in managing inflammatory pain [15]. However, robust research and collaboration are crucial to ensuring their safe and effective integration alongside existing therapies.
Potential setbacks include the scarcity of relevant studies and the heterogeneity of interventions and outcome measures. To overcome these challenges, a comprehensive search strategy will be employed, and experts in the field will be consulted. Despite these setbacks, this review is expected to yield valuable insights for healthcare professionals and identify research gaps, thus improving pain management and quality of life for patients with ADs in Africa.
Conclusion
In conclusion, this systematic review and meta-analysis will aim to fill the knowledge gap regarding the effectiveness of non-pharmacological therapies for managing chronic pain in people with ADs in Africa. The findings from this study will provide valuable insights into the potential benefits of interventions such as exercise, physical therapy, cognitive-behavioral therapy, mindfulness, and meditation. These insights will inform evidence-based decision-making, improve pain management strategies, and enhance the quality of care and quality of life for individuals in this population. Furthermore, the comprehensive synthesis of the available evidence may also inform clinical practice and future research in this field.
References
- 1. Conrad N., Misra S., Verbakel J.Y., Verbeke G., Molenberghs G., Taylor P.N., et al., Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK. The Lancet, 2023. 401(10391): p. 1878–1890. pmid:37156255
- 2. Wang L., Wang F.S., and Gershwin M.E., Human autoimmune diseases: a comprehensive update. Journal of internal medicine, 2015. 278(4): p. 369–395. pmid:26212387
- 3. Lerner A., Jeremias P., and Matthias T., The world incidence and prevalence of autoimmune diseases is increasing. Int J Celiac Dis, 2015. 3(4): p. 151–5.
- 4. Pisetsky D.S., Pathogenesis of autoimmune disease. Nature Reviews Nephrology, 2023: p. 1–16.
- 5. Soyuer F. and Kepenek-Varol B., Quality of life and pain. International Journal of Family and Community Medicine, 2019. 3(3): p. 110–114.
- 6. Aletaha D. and Smolen J.S., Diagnosis and management of rheumatoid arthritis: a review. Jama, 2018. 320(13): p. 1360–1372. pmid:30285183
- 7. Mathias K., Amarnani A., Pal N., Karri J., Arkfeld D., Hagedorn J.M., et al., Chronic pain in patients with rheumatoid arthritis. Current Pain and Headache Reports, 2021. 25: p. 1–11.
- 8. Fugger L., Jensen L.T., and Rossjohn J., Challenges, progress, and prospects of developing therapies to treat autoimmune diseases. Cell, 2020. 181(1): p. 63–80. pmid:32243797
- 9. James P.B., Wardle J., Steel A., and Adams J., Traditional, complementary and alternative medicine use in Sub-Saharan Africa: a systematic review. BMJ global health, 2018. 3(5): p. e000895. pmid:30483405
- 10.
Higgins JPT, T.J., Chandler J, Cumpston M, Li T, Page MJ, Welch VA(editors), Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023). Cochrane, 2023. Available from www.training.cochrane.org/handbook.
- 11.
Wells G., Shea B., O’connell D., Peterson J., Welch V., Losos M., et al., Newcastle-Ottawa quality assessment scale cohort studies. University of Ottawa, 2014.
- 12. Higgins J.P., Savović J., Page M.J., Elbers R.G., and Sterne J.A., Assessing risk of bias in a randomized trial. Cochrane handbook for systematic reviews of interventions, 2019: p. 205–228.
- 13. Long H.A., French D.P., and Brooks J.M., Optimising the value of the critical appraisal skills programme (CASP) tool for quality appraisal in qualitative evidence synthesis. Research Methods in Medicine & Health Sciences, 2020. 1(1): p. 31–42.
- 14. Page M.J., McKenzie J.E., Bossuyt P.M., Boutron I., Hoffmann T.C., Mulrow C.D., et al., The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Bmj, 2021. 372.
- 15. Khumalo G.P., Van Wyk B.E., Feng Y., and Cock I.E., A review of the traditional use of southern African medicinal plants for the treatment of inflammation and inflammatory pain. Journal of Ethnopharmacology, 2022. 283: p. 114436. pmid:34289396